Chemours (NYSE:CC) Price Target Lowered to $30.00 at BMO Capital Markets
Chemours (NYSE:CC – Free Report) had its price objective decreased by BMO Capital Markets from $35.00 to $30.00 in a report published on Tuesday morning, Benzinga reports. BMO Capital Markets currently has an outperform rating on the specialty chemicals company’s stock. Several other research analysts have also recently weighed in on the company. UBS Group […]
More Stories
Vanguard S&P 500 ETF (NYSEARCA:VOO) Position Increased by Wealth Dimensions Group Ltd.
Wealth Dimensions Group Ltd. lifted its holdings in Vanguard S&P 500 ETF (NYSEARCA:VOO – Free Report) by 4.7% during the...
Marco Investment Management LLC Raises Position in Thermo Fisher Scientific Inc. (NYSE:TMO)
Marco Investment Management LLC increased its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 3.1%...
766 Shares in S&P Global Inc. (NYSE:SPGI) Bought by Hartford Funds Management Co LLC
Hartford Funds Management Co LLC purchased a new stake in S&P Global Inc. (NYSE:SPGI – Free Report) during the 3rd...
Marco Investment Management LLC Decreases Stock Position in The Coca-Cola Company (NYSE:KO)
Marco Investment Management LLC reduced its position in The Coca-Cola Company (NYSE:KO – Free Report) by 5.2% in the third...
Marco Investment Management LLC Has $11.05 Million Stock Position in Merck & Co., Inc. (NYSE:MRK)
Marco Investment Management LLC lifted its position in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 3.4%...
3M (NYSE:MMM) Shares Sold by Cahill Financial Advisors Inc.
Cahill Financial Advisors Inc. lowered its holdings in shares of 3M (NYSE:MMM – Free Report) by 2.8% in the third...